In a trial, Achieve's cytisinicline helped smokers quit without major side effec...
Biotech venture capital may be pacing at a six-year low, but one startup just ma...
"There isn't enough evidence" that social media is safe for kids, U.S. Surgeon G...
The biggest challenge of using generative AI in medicine is the hallucination pr...
STAT obtained new data that reveals federal prisoners at the highest risk for Co...
STAT asked experts to debunk the many misconceptions swirling around generative ...
Will error-riddled medical records used to train AI models throw off results? An...
When patients with serious illnesses confront high deductibles, they make decisi...
The FDA on Monday approved a new, easy-to-use version of a medication to reverse...
With more effective treatments available, a study finds that screening all Ameri...
As Seagen prepares to be acquired by Pfizer, an investor advisory firm is raisin...
Adding an oral option of Ozempic and Wegovy would give Novo Nordisk “the first s...
A FDA advisory panel voted against approving an investigational treatment from I...
The well-intended "screen and refer" system is not only ineffective but also deh...
Vyjuvek is claimed to be the first and only FDA-approved treatment for both rece...
Up to £24m will be used to strengthen the UK’s collaboration with CARB-X.
